News Daily News Long-term Evolocumab Safe, Effective for Familial Hypercholesterolemia Treatment Yael L. Maxwell February 12, 2020
News Daily News Trials of New Cancer Drugs Failing to Address Potential CV Risks Todd Neale February 10, 2020
News Daily News Free Pass? Lifestyle Slips for Patients Starting Certain Preventive Meds Michael O'Riordan February 06, 2020
News Daily News Pot Talk: Review Urges Cardiologists to Discuss Marijuana Use L.A. McKeown January 21, 2020
News Daily News Hypertension Starts Years Earlier in Women Than Men, Serial BP Shows L.A. McKeown January 17, 2020
News Daily News Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes Michael O'Riordan January 14, 2020
News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Daily News Most Secondary Prevention Patients Are Eligible for Multiple Drugs Michael O'Riordan January 03, 2020
News Daily News AHA Plugs ‘Dietary Patterns’ Over Dietary Cholesterol Targets Yael L. Maxwell December 26, 2019
News Daily News Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019 Yael L. Maxwell December 20, 2019
News Daily News Aspirin Not Protective Against CVD in Black Patients Caitlin E. Cox December 18, 2019
News Daily News Anticoagulation Prescription in the ED May Boost Later Use Todd Neale December 11, 2019
News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Daily News Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk Michael O'Riordan December 03, 2019
News Daily News Many ASCVD Patients Skimp on CV Meds Due to Costs: US Survey Caitlin E. Cox November 25, 2019
News Conference News AHA 2019 Inclisiran in FH: Safe, Cuts LDL in This Challenging Group Yael L. Maxwell November 19, 2019
News Conference News AHA 2019 Inclisiran Slashes LDL in ASCVD Patients: ORION-10 Yael L. Maxwell November 16, 2019
News Conference News AHA 2019 COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine Caitlin E. Cox November 16, 2019
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Conference News AHA 2019 More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA Michael O'Riordan November 14, 2019